Blinded Post Trial Therapy


Indications and Reactions:

Role Indications Reactions
Primary
Glioblastoma Multiforme 100.0%
Atrial Tachycardia 50.0%
Blood Lactic Acid Increased 50.0%
Secondary
Hepatitis C 23.6%
Acute Coronary Syndrome 9.1%
Prophylaxis 9.0%
Prophylaxis Of Nausea And Vomiting 8.8%
Chronic Hepatitis C 8.5%
Hypertension 6.9%
Type 2 Diabetes Mellitus 6.2%
Osteoporosis Postmenopausal 5.3%
Myelodysplastic Syndrome 4.4%
Chemotherapy 3.3%
Non-small Cell Lung Cancer 2.7%
Diabetes Mellitus 2.4%
Infertility 2.2%
Neuromuscular Blockade Reversal 1.3%
Depression 1.3%
Acute Myeloid Leukaemia 1.1%
High Density Lipoprotein Decreased 1.1%
Product Used For Unknown Indication 1.1%
Routine Health Maintenance 1.1%
Bipolar I Disorder 0.9%
Neutropenia 11.6%
Febrile Neutropenia 10.7%
Drug Dispensing Error 8.9%
Vomiting 8.0%
Tooth Disorder 7.1%
White Blood Cell Count Decreased 5.4%
Osteoarthritis 4.5%
Renal Failure Acute 4.5%
Allergic Transfusion Reaction 3.6%
Anaemia 3.6%
Anaphylactic Reaction 3.6%
Ascites 3.6%
Deep Vein Thrombosis 3.6%
Encephalopathy 3.6%
Interstitial Lung Disease 3.6%
No Adverse Event 3.6%
Respiratory Failure 3.6%
Bronchitis 2.7%
Hip Arthroplasty 2.7%
Basal Cell Carcinoma 1.8%

Drug Data